SARAH BYRD: Open Payments
NPI 1205416799 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 81 payments from 19 companies in 2025. Trend: 2023 $1,746 · 2024 $2,136 · 2025 $1,543
Food & beverage: $1,500Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $167 |
| Novo Nordisk Inc | 7 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $136 |
| Tandem Diabetes Care, Inc. | 6 | $133 |
| SANOFI-AVENTIS U.S. LLC | 7 | $129 |
| Lilly USA, LLC | 8 | $123 |
| Medtronic, Inc. | 5 | $118 |
| Antares Pharma, Inc. | 5 | $84 |
| Amgen Inc. | 4 | $66 |
| Mannkind Corporation | 2 | $59 |
Products named: JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, TZIELD, MOUNJARO, MINIMED 780G, Ozempic, XYOSTED, Rybelsus.
Industry payments across AL — which companies pay providers there.
